FTSE starts new week in slightly stronger mode
Fiona Cincotta September 30, 2019 10:04 AM
The GlaxoSmithKline vs AstraZeneca race to capture the market for ovarian cancer drugs put Glaxo in the lead this morning with the release of the data for its latest drug showing an improvement on AstraZeneca’s most recent product. The two companies are almost neck-a-neck in developing drugs for this specific type of cancer and the release helped Glaxo gain 1.6% while AstraZeneca slipped 1.8%.
UK GDP, Conservative conference to steer sterling trade
Pound crosses will be in focus in the forex market later this morning after the UK reports its final numbers for second quarter GDP. Brexit uncertainty is expected to have continued to erode GDP growth between April and June compared with the first quarter but year on year GDP should still be showing some improvement.
Otherwise the pound is a touch firmer as the Conservative Party starts its conference in Manchester which is likely to see a replay of the heated debates at Labour’s party conference witnessed last week as the party remains deeply divided over what course to take next.
Brent crude is trading just a whisker above $60 after Chinese PMI data showed that the country’s manufacturing is still teetering on the verge of contraction.
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.